LOS ANGELES--(BUSINESS WIRE)--Canopus BioPharma, Inc. (OTCPK: CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients suffering from infectious disease, radiation sickness, cancer, and addiction, announced today that it will present at the Rodman & Renshaw 5th Annual Global Healthcare Conference in Monte Carlo, Monaco on Monday, May 19, at 4:25 AM Eastern (10:25 AM Central European Summer Time).
